134
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Pioglitazone ameliorates hepatic damage in irradiated rats via regulating anti-inflammatory and antifibrogenic signalling pathways

ORCID Icon & ORCID Icon
Pages 748-757 | Received 21 Feb 2019, Accepted 17 May 2019, Published online: 19 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ying Jie Zhou, Yun Tang, Si Jian Liu, Peng Hui Zeng, Li Qu, Qian Cheng Jing & Wen Jun Yin. (2023) Radiation-induced liver disease: beyond DNA damage. Cell Cycle 22:5, pages 506-526.
Read now

Articles from other publishers (7)

Marco Greco, Anas Munir, Debora Musarò, Chiara Coppola & Michele Maffia. (2023) Restoring autophagic function: a case for type 2 diabetes mellitus drug repurposing in Parkinson’s disease. Frontiers in Neuroscience 17.
Crossref
Siva Dallavalasa, SubbaRao V. Tulimilli, Janhavi Prakash, Ramya Ramachandra, SubbaRao V. Madhunapantula & Ravindra P. Veeranna. (2023) COVID-19: Diabetes Perspective—Pathophysiology and Management. Pathogens 12:2, pages 184.
Crossref
Han Song, Yunye Li, Ruiming Yu, Xiangbin Meng & Yanwen Bi. (2023) Change in left ventricular diastolic function after pioglitazone treatment in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis. Medicine 102:1, pages e32613.
Crossref
Wei Zhu, Xiaofen Zhang, Mengli Yu, Bingru Lin & Chaohui Yu. (2021) Radiation-induced liver injury and hepatocyte senescence. Cell Death Discovery 7:1.
Crossref
Weronika Bielka, Agnieszka Przezak & Andrzej Pawlik. (2021) Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection. International Journal of Molecular Sciences 22:14, pages 7605.
Crossref
Bao Sun, Shiqiong Huang & Jiecan Zhou. (2021) Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections. Frontiers in Pharmacology 11.
Crossref
Theano Penlioglou, Stella Papachristou & Nikolaos Papanas. (2020) COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?. Diabetes Therapy 11:6, pages 1195-1197.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.